Posner Christopher - Insider Non-Derivative Transactions at Cara Therapeutics, Inc. (CARA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 1, 2024, Posner Christopher's relationship to Cara Therapeutics, Inc. (CARA) is Director,Officer (PRESIDENT AND CEO), and currently has 172,436 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CARA insiders.

Data Source: SEC.
Posner Christopher - Insider Non-Derivative Transactions of CARA Common Stock
Posner Christopher - Insider Non-Derivative Transactions at CARA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 2, 2024 Sell -- (Common Stock) 4149 0.35 172436
May 3, 2024 Sell -- (Common Stock) 3936 0.75 176585
Mar 1, 2024 Sell -- (Common Stock) 5834 0.89 180521
Feb 9, 2024 Sell -- (Common Stock) 35575 0.53 186355
Feb 2, 2024 Sell -- (Common Stock) 4981 0.55 221930
Feb 2, 2024 Acquisition -- (Common Stock) 62500 0 226911
Nov 3, 2023 Sell -- (Common Stock) 3796 1.22 164411
Aug 4, 2023 Sell -- (Common Stock) 4307 3.07 168207
May 6, 2023 Sell -- (Common Stock) 3869 4.4 172514
Mar 4, 2023 Sell -- (Common Stock) 5987 9.71 176383
Feb 3, 2023 Sell -- (Common Stock) 4191 11.8 182370